calcitonin (Human) [1614]



calcitonin (Human)


SMILES CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CSSC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NC([C@@H](C)O)C(=O)N1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(N)=O)C(C)C
InChIKey LDVRMNJZLWXJPL-GXQFRRLTSA-N
Sequence CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP
HELM PEPTIDE1{C.G.N.L.S.[*C(=O)C([C@@H](C)O)N* |$_R2;;;;;;;;_R1$|].C.M.L.G.T.Y.T.Q.D.F.N.K.F.H.T.F.P.Q.T.A.I.G.V.G.A.P.[am]}$PEPTIDE1,PEPTIDE1,1:R3-7:R3$$$

Chemical Properties

Hydrogen bond acceptors 50
Hydrogen bond donors 45
Rotatable bonds 91
Log P -16.228
Molecular weight (Da) 3415.6
Stereochemistry info partial


No bioactivity data available.

calcitonin (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.